Advances in Pulmonary Drug Delivery Systems and Inhalation Formulations.
作者信息
Lam Jenny K W, Zhou Qi Tony
机构信息
Department of Pharmaceutics, UCL School of Pharmacy, University College London, London, UK.
Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN, 47907, USA.
出版信息
Pharm Res. 2023 May;40(5):1013-1014. doi: 10.1007/s11095-023-03534-9.
Abstract
摘要
相似文献
1
Advances in Pulmonary Drug Delivery Systems and Inhalation Formulations.肺部给药系统与吸入制剂的进展
Pharm Res. 2023 May;40(5):1013-1014. doi: 10.1007/s11095-023-03534-9.
2
Editorial: Pulmonary Delivery of Systemic Drugs- from Aerosol Generation to Efficacious Delivery.社论：全身用药的肺部给药——从气雾剂产生到有效递送
Curr Pharm Des. 2016;22(17):2451-2. doi: 10.2174/1381612822999160321124803.
3
Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.用于肺部给药的吸入纳米治疗药物的药代动力学
J Control Release. 2020 Oct 10;326:222-244. doi: 10.1016/j.jconrel.2020.07.011. Epub 2020 Jul 16.
4
Recent Advances in Inhaled Formulations and Pulmonary Insulin Delivery Systems.吸入制剂和肺部胰岛素递药系统的最新进展。
Curr Pharm Biotechnol. 2020;21(3):180-193. doi: 10.2174/1389201020666191011152248.
5
Selected Engineering and Physicochemical Aspects of Systemic Drug Delivery by Inhalation.吸入式全身给药的选定工程学和物理化学方面
Curr Pharm Des. 2016;22(17):2453-62. doi: 10.2174/1381612822666160128145644.
6
Pulmonary and Regional Deposition of Nebulized and Dry Powder Aerosols in Ferrets.雾化和干粉气溶胶在雪貂中的肺部和区域性沉积。
AAPS PharmSciTech. 2019 Jul 1;20(6):242. doi: 10.1208/s12249-019-1382-3.
7
Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers.吸入式微/纳粒抗癌药物制剂：一种针对肺癌的新兴靶向药物传递策略。
Curr Cancer Drug Targets. 2019;19(3):162-178. doi: 10.2174/1568009618666180525083451.
8
Recent advances in liposomal dry powder formulations: preparation and evaluation.脂质体干粉制剂的最新进展：制备与评价
Expert Opin Drug Deliv. 2009 Jan;6(1):71-89. doi: 10.1517/17425240802652309.
9
Formulation techniques for high dose dry powders.高剂量干粉制剂技术。
Int J Pharm. 2018 Aug 25;547(1-2):489-498. doi: 10.1016/j.ijpharm.2018.05.036. Epub 2018 May 17.
10
Pulmonary vaccine delivery.肺部疫苗递送
Expert Rev Vaccines. 2007 Apr;6(2):213-26. doi: 10.1586/14760584.6.2.213.
引用本文的文献
1
Comprehensive physicochemical, biophysical, and characterization of lung surfactant SP-A peptidomimetics.肺表面活性物质SP - A拟肽的综合物理化学、生物物理及表征
RSC Pharm. 2025 May 6. doi: 10.1039/d4pm00265b.
2
Inhalable Nano Formulation of Cabazitaxel: A Comparative Study with Intravenous Route.卡巴他赛的可吸入纳米制剂：与静脉途径的比较研究。
Macromol Biosci. 2025 May;25(5):e2400567. doi: 10.1002/mabi.202400567. Epub 2025 Jan 30.
3
Nanomedicines for Pulmonary Drug Delivery: Overcoming Barriers in the Treatment of Respiratory Infections and Lung Cancer.用于肺部给药的纳米药物：克服呼吸道感染和肺癌治疗中的障碍
Pharmaceutics. 2024 Dec 11;16(12):1584. doi: 10.3390/pharmaceutics16121584.
本文引用的文献
1
Recent Advances in Inhaled Nanoformulations of Vaccines and Therapeutics Targeting Respiratory Viral Infections.吸入式纳米制剂在呼吸道病毒感染疫苗和治疗中的最新进展。
Pharm Res. 2023 May;40(5):1015-1036. doi: 10.1007/s11095-023-03520-1. Epub 2023 Apr 25.
2
Central and peripheral lung deposition of fluticasone propionate dry powder inhaler formulations in humans characterized by population pharmacokinetics.应用群体药代动力学特征描述丙酸氟替卡松干粉吸入剂在人体中的肺部中央和周边沉积。
Pharm Res. 2023 May;40(5):1177-1191. doi: 10.1007/s11095-023-03472-6. Epub 2023 Apr 20.
3
Design Considerations for Intratracheal Delivery Devices to Achieve Proof-of-Concept Dry Powder Biopharmaceutical Delivery in Mice.实现小鼠干粉末生物制药传递的气管内输送装置的设计考虑因素。
Pharm Res. 2023 May;40(5):1165-1176. doi: 10.1007/s11095-023-03492-2. Epub 2023 Mar 29.
4
Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis.载 D-LAK 抗菌肽和卷曲霉素的联合递药吸入粉体制剂用于治疗耐药结核病。
Pharm Res. 2023 May;40(5):1073-1086. doi: 10.1007/s11095-023-03488-y. Epub 2023 Mar 3.
5
Aerosolizable Plasmid DNA Dry Powders Engineered by Thin-film Freezing.薄膜冷冻工程化的可气溶胶化质粒 DNA 干粉
Pharm Res. 2023 May;40(5):1141-1152. doi: 10.1007/s11095-023-03473-5. Epub 2023 Jan 26.
6
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration.大麻二酚治疗脑部疾病：治疗潜力和给药途径。
Pharm Res. 2023 May;40(5):1087-1114. doi: 10.1007/s11095-023-03469-1. Epub 2023 Jan 12.
7
Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery.喷雾冷冻干燥生物制剂：综述及吸入给药应用。
Pharm Res. 2023 May;40(5):1115-1140. doi: 10.1007/s11095-022-03442-4. Epub 2022 Dec 1.
8
In vitro Dissolution Testing of Rifampicin Powder Formulations For Prediction of Plasma Concentration-Time Profiles After Inhaled Delivery.利福平粉末制剂的体外溶出度测试预测吸入给药后的血浆浓度-时间曲线。
Pharm Res. 2023 May;40(5):1153-1163. doi: 10.1007/s11095-022-03439-z. Epub 2022 Nov 29.
9
Challenges and Strategies to Enhance the Systemic Absorption of Inhaled Peptides and Proteins.增强吸入型肽和蛋白质系统性吸收的挑战与策略。
Pharm Res. 2023 May;40(5):1037-1055. doi: 10.1007/s11095-022-03435-3. Epub 2022 Nov 16.
10
Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment.新兴抗菌药物肺部递药治疗细菌性肺部感染
Pharm Res. 2023 May;40(5):1057-1072. doi: 10.1007/s11095-022-03379-8. Epub 2022 Sep 19.
Zotero 插件